News

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve ...
Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome ...
This event will feature discussions on novel immune checkpoint inhibitors, personalized cancer vaccines and CAR T-Cell therapies. We will also address the challenges of translating basic research into ...
The Technology Networks team attended ASMS 2025 and spoke with Jim Gearing, who discusses the challenges that contaminant analysts face, and how Agilent are addressing these challenges by developing ...
At ASMS 2025, the Technology Networks team caught up with Jim Gearing, Associate Vice President of Marketing, Gas Phase ...
In an advancement for soil science, researchers from Japan have developed a novel method for estimating microbial biomass ...
We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...
A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors ...
While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects ...
Researchers discovered two distinct ways in which the mutation of the FOXA1 gene alters tumor formation and therapy ...
Exposing muscle cells to microgravity mirrors sarcopenia, helping researchers understand how muscle cells weaken with age.
Researchers at the Keck School of Medicine developed a tau PET imaging cut-point to identify early Alzheimer’s signs. The cut ...